[go: up one dir, main page]

HK1139076A1 - Lyophilized preparation comprising influenza vaccine, and method for preparation thereof - Google Patents

Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Info

Publication number
HK1139076A1
HK1139076A1 HK10105830.1A HK10105830A HK1139076A1 HK 1139076 A1 HK1139076 A1 HK 1139076A1 HK 10105830 A HK10105830 A HK 10105830A HK 1139076 A1 HK1139076 A1 HK 1139076A1
Authority
HK
Hong Kong
Prior art keywords
influenza vaccine
preparation
freeze
iii
dried preparation
Prior art date
Application number
HK10105830.1A
Other languages
English (en)
Inventor
Chikamasa Yamashita
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1139076A1 publication Critical patent/HK1139076A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK10105830.1A 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof HK1139076A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007059724 2007-03-09
PCT/JP2008/054210 WO2008111532A1 (ja) 2007-03-09 2008-03-07 インフルエンザワクチン含有凍結乾燥製剤、及びその製造方法

Publications (1)

Publication Number Publication Date
HK1139076A1 true HK1139076A1 (en) 2010-09-10

Family

ID=39759470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105830.1A HK1139076A1 (en) 2007-03-09 2010-06-10 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof

Country Status (20)

Country Link
US (1) US8216588B2 (zh)
EP (1) EP2119451A4 (zh)
JP (1) JP5388842B2 (zh)
KR (1) KR20090128463A (zh)
CN (1) CN101631563B (zh)
AR (1) AR065640A1 (zh)
AU (1) AU2008225501B2 (zh)
BR (1) BRPI0808037A2 (zh)
CA (1) CA2680193C (zh)
HK (1) HK1139076A1 (zh)
IL (1) IL200588A0 (zh)
MX (1) MX2009009635A (zh)
MY (1) MY149924A (zh)
NZ (1) NZ579395A (zh)
RU (1) RU2484847C2 (zh)
SG (1) SG179406A1 (zh)
TW (1) TWI428140B (zh)
UA (1) UA97391C2 (zh)
WO (1) WO2008111532A1 (zh)
ZA (1) ZA200905952B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614460D0 (en) * 2006-07-20 2006-08-30 Novartis Ag Vaccines
CN103620025A (zh) * 2011-06-28 2014-03-05 白血球保健股份有限公司 病毒或细菌的新型稳定方法
PL2948129T3 (pl) * 2013-01-25 2018-05-30 Wintermute Biomedical, Inc. Związki terapeutyczne
GB201314248D0 (en) * 2013-08-08 2013-09-25 Glaxosmithkline Biolog Sa Saccharide vaccine formulation
EP3041504B1 (en) * 2013-09-03 2021-08-25 Georgia Tech Research Corporation Thermally stable vaccine formulations and microneedles
EP3060247A1 (en) * 2013-10-25 2016-08-31 Leukocare Ag A novel method for the production of stabile vaccines
WO2017090766A1 (ja) 2015-11-27 2017-06-01 日東電工株式会社 口腔内投与用ワクチン医薬組成物及び口腔内投与用ワクチン医薬組成物の製造方法
TW201722478A (zh) * 2015-11-27 2017-07-01 Nitto Denko Corp 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法
TW201720426A (zh) * 2015-11-27 2017-06-16 Nitto Denko Corp 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法
US11065220B2 (en) 2017-02-13 2021-07-20 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
WO2020072479A1 (en) 2018-10-01 2020-04-09 Wintermute Biomedical, Inc. Therapeutic compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4537769A (en) 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
JPH05229960A (ja) * 1990-10-30 1993-09-07 Dai Ichi Seiyaku Co Ltd 新規インフルエンザワクチン
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ３型ウイルス感染症、牛ｒｓウイルス感染症および牛アデノ７型ウイルス感染症５種混合生ワクチン
AU2001244584B2 (en) * 2000-03-31 2006-01-19 Kirin Pharma Kabushiki Kaisha Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
JP2004054555A (ja) * 2002-07-19 2004-02-19 Yokogawa Electric Corp 表示装置
CN101804202B (zh) 2003-02-25 2014-06-18 米迪缪尼有限公司 制备流感疫苗组合物的方法
KR101346989B1 (ko) * 2004-10-06 2014-02-06 메디뮨 엘엘씨 냉장 온도 안정성 인플루엔자 백신 조성물
RU2290205C1 (ru) * 2005-09-13 2006-12-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации Способ получения живой вакцины для профилактики гриппа

Also Published As

Publication number Publication date
KR20090128463A (ko) 2009-12-15
CN101631563B (zh) 2013-07-24
RU2009137380A (ru) 2011-04-20
ZA200905952B (en) 2010-11-24
WO2008111532A1 (ja) 2008-09-18
US8216588B2 (en) 2012-07-10
AU2008225501A2 (en) 2009-09-24
AU2008225501B2 (en) 2013-08-29
AU2008225501A1 (en) 2008-09-18
CN101631563A (zh) 2010-01-20
IL200588A0 (en) 2010-05-17
MY149924A (en) 2013-10-31
MX2009009635A (es) 2009-09-22
EP2119451A4 (en) 2012-05-16
TW200848074A (en) 2008-12-16
JPWO2008111532A1 (ja) 2010-06-24
EP2119451A1 (en) 2009-11-18
TWI428140B (zh) 2014-03-01
CA2680193C (en) 2015-05-05
JP5388842B2 (ja) 2014-01-15
UA97391C2 (ru) 2012-02-10
AR065640A1 (es) 2009-06-17
NZ579395A (en) 2012-05-25
BRPI0808037A2 (pt) 2014-06-17
CA2680193A1 (en) 2008-09-18
SG179406A1 (en) 2012-04-27
RU2484847C2 (ru) 2013-06-20
US20100104595A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
HK1139076A1 (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
MX2012000036A (es) Vacuna.
WO2007035455A3 (en) Stabilizers for freeze-dried vaccines
CA2746228C (en) Modified rsv f proteins and methods of their use
HRP20200101T1 (hr) Glikopeptidni pripravci
EA202090053A2 (ru) Способы и композиции для лечения неэффективного эритропоэза
JP2017533218A5 (zh)
WO2007048086A3 (en) Canine influenza virus and related compositions and methods of use
WO2012061815A3 (en) RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs)
PE20100035A1 (es) Proteina de cereal hidrolizado parcialmente
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
RS54822B1 (sr) Kompozicija i formulacija koja obuhvata rekombinovanu humanu iduronat-2-sulfatazu i postupak za njeno dobijanje
NZ600891A (en) Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
EP3210622A3 (en) Recombinant avian paramyxovirus vaccine and method for making and using thereof
WO2012115474A3 (ko) 신규한 수두 대상포진 바이러스주 및 이를 이용한 수두 및 대상포진 바이러스 백신
WO2009118754A3 (en) A process for preparing a stable lyophilized composition
MX349837B (es) Composicion de transglutaminasa seca.
WO2011051916A3 (en) Stabilized protein formulations and use thereof
NZ613554A (en) Caprylate viral deactivation
ATE415151T1 (de) Formulierung zur verzögerten freisetzung von valproinsäure und deren derivate
TH108771A (th) สารปรุงสำเร็จที่แห้งแบบเยือกแข็งที่มีวัคซีนไข้หวัดใหญ่ และวิธีสำหรับผลิตสารดังกล่าว
MX2015009141A (es) Formulaciones de albu-bche, preparacion y usos de las mismas.
WO2010095978A3 (ru) Способ получения препарата проинсулина для перорального применения
NZ704819A (en) Dry powder vancomycin compositions and associated methods
NZ704819B2 (en) Dry powder vancomycin compositions and associated methods

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170307